This article contains promotionsWhen aspiration pneumonia occurs, we first begin treatment. Depending on the patient's ...

Adverse events tied to proliferative diabetic retinopathy affected 6.7% and 6.1% of remigromig patients, versus 0.9% with ranibizumab; BAROLO continues.

A large target trial emulation found that continuing GLP-1 receptor agonists before thyroidectomy in adults with type 2 ...

The lead investigator of Japan's JASMINE trial has published a detailed response defending the open-label design, third-party ...

Objective To explore experiences and perceptions of financial incentives from children and young people (CYP) involved in the ...

This article investigates the introduction of the Huntington’s Disease Integrated Staging System (HD-ISS) in research ...

Introduction Embolization of the middle meningeal artery (EMMA) is an emerging treatment for chronic subdural hematoma (cSDH) ...

Enrollment completed in Part C of THIO-101 Phase 2 study; 65% of 2026 enrollment target reached in pivotal THIO-104 Phase 3 ...

Neurostimulants could improve Glasgow Coma Scale scores and reduce ICU length of stay for patients with disorders of consciousness.

The peer-reviewed clinical study conducted by Skinome Research AB has evaluated the efficacy and tolerability of a minimalist ...

September 30, 2026, surpassing full trial enrollment targetCompany reiterates prior guidance: primary endpoint data to be submitted for late-breaking presentation consideration at a major ...

Tesamorelin can selectively reduce visceral fat, as demonstrated in RCTs. But the real story is what it reveals about ...